R Squared’s Tandem Diabetes Care TNDM Stock Holding History

R Squared’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-270	Closed	-$9.72K	–	1411
2024 Q4	$9.72K	Buy	+270	New	+$9.13K	0.01%	1160

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

R Squared's TNDM Position: Q1 2025 in Review

R Squared sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 270 shares — an estimated $9.72K sold.

R Squared first reported a position in TNDM in Q4 2024 and held it in 1 quarter. The position peaked at $9.72K in Q4 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

R Squared reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
R Squared sold 270 Tandem Diabetes Care shares in Q1 2025, an estimated $9.72K.
R Squared first reported a position in Tandem Diabetes Care in Q4 2024 and held it in 1 quarter.
R Squared's Tandem Diabetes Care position peaked at $9.72K in Q4 2024.
275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.